Actively Recruiting
Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing
Led by Janice Hernandez, MD · Updated on 2025-12-17
20
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the use of a hydrocolloid dressing called DuoDERM EXTRA THIN for wound healing in patients undergoing oculofacial plastic and reconstructive surgery, including Mohs micrographic surgery. The study aims to compare this dressing with the current standard care involving antibiotic ophthalmic ointment to see if it can reduce the need for ointment application and lessen the burden of post-operative care. This is a randomized interventional trial without masking. At the end of the surgical procedure, participants will receive either the hydrocolloid wound dressing applied once to the sutured periocular wounds or the standard topical antibiotic ophthalmic ointment. The dressing is intended to be left in place until it is removed at a one-week post-operative visit. These two approaches represent the experimental and control groups of the study. Participants will be followed up in an office setting at 1 week, 6 weeks, and 3 months after surgery. Researchers will assess wound healing outcomes, including the number of participants experiencing wound opening (dehiscence) at 3 months. They will also use the Patient and Observer Scar Assessment Scale at 3 months to evaluate scar appearance. The study will monitor safety and effectiveness during these visits, with total participation lasting about three months.
CONDITIONS
Brief Title
Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over 18 years of age
- Able to attend follow-up visits at 1 week, 6 weeks, and 3 months in an office setting
- Able to give informed consent
- No exclusion based on gender, ethnicity, or religious background
You will not qualify if you...
- Patients under 18 years or over 100 years of age
- Allergy to pectin, gelatin, or sodium carboxymethylcellulose
- Adults unable to provide informed consent
- Individuals who are incarcerated
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Surgery day
Participants undergo oculofacial plastic surgery and receive a one-time application of either a hydrocolloid wound dressing or antibiotic ophthalmic ointment to the surgical sutured periocular wounds.
1 visit (in-person)
Duration - 3 months
Participants attend follow-up visits to monitor wound healing and assess scar appearance.
Visits at 1 week, 6 weeks, and 3 months (in-person)
Trial Site Locations
Total: 1 location
1
University of Kentucky
Lexington, Kentucky, United States, 40508
Actively Recruiting
Research Team
C
Connie Dampier
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here